wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47788774-32C80B01-C6A2-4E72-BD1A-EBE34F36EF65
Q47788774-32C80B01-C6A2-4E72-BD1A-EBE34F36EF65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47788774-32C80B01-C6A2-4E72-BD1A-EBE34F36EF65
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
P2860
Q47788774-32C80B01-C6A2-4E72-BD1A-EBE34F36EF65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47788774-32C80B01-C6A2-4E72-BD1A-EBE34F36EF65
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd5183b2577e1c53d74ab152640539652f4744a3
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105